Billions of dollars of regulations are being added each day, crushing Main Street.

The Biden Administration should take a page from the Trump Administration and slash burdensome red tape.

Consumer sentiment tumbled to the lowest level in six months!

Americans are still paying the price for the Biden Administration’s extreme agenda.
bloomberg.com/news/articles/…

✅ Fact Check: Biden’s policies drove inflation to a 40-year high.

His tax and spend agenda caused it and small businesses are stuck paying the price.
foxbusiness.com/politics/biden…

Today, Chairman Rep. Roger Williams along with Pete Stauber, Congresswoman Beth Van Duyne, Rep. Jake Ellzey, and Aaron Bean wrote to the FTC over its rules regarding Junk Fees and their impacts on small businesses. Every small business deserves to have their needs taken into consideration.

Read…

Today, Chairman Rep. Roger Williams along with Pete Stauber, Congresswoman Beth Van Duyne, Rep. Jake Ellzey, and Aaron Bean wrote to the consumerfinance.gov over its rule prohibiting fees on instantaneously declined transactions, making an already burdensome law even more complicated.

Read more below.…

The House Committee on Small Business Committee is working hard to hold the Biden Administration accountable and ensure that the SBA is focused on small business, not politics. Let them know you support their efforts! p2a.co/28hJWoz

🚨The Biden Administration is using the Small Business Administration to register voters in Michigan.

The SBA is supposed to help small businesses, but Biden is more worried about winning reelection.
dailywire.com/news/federal-g…

Nearly 75% of small businesses say inflationary pressures have increased in the past three months.

Main Street is already struggling, and Biden’s far-left policies are only making things worse.
goldmansachs.com/citizenship/10…

During Small Business Week and at the start of National Beef Month, I was pleased to welcome representatives from Yoder Meats to our nation's capital for the House Committee on Small Business Showcase - just one example of the countless small businesses that flourish in the Sunflower State.

The phase-out of the R&D Tax Credit is hitting small businesses hard, particularly those in the medical field dedicated to creating breakthrough medicines. Developing new treatments already carries a substantial price tag. Losing the ability to fully deduct their research…

Burdensome regulations shouldn’t stand between patients and quality healthcare.

Unfortunately, as Congressman Nick LaLota shows, these regulations create an uneven playing field that disadvantages small healthcare providers.

As @RepMolnaroNY19 lays out, small providers are key, especially in rural areas.

Unfortunately, high regulatory costs drive these firms to consolidate leaving rural patients stranded. Lessening the regulatory burden will help everyone involved.

The FDA approval process is far too burdensome and unsustainable for smaller firms, per Rep. Celeste Maloy.

Congress needs to work to remove some of these burdens without also getting in the way.

As Rep. Mark Alford lays out, when rural providers are hit with high costs, they have to close down, leaving patients stranded.

Burdensome regulations have an even more adverse effect on those in rural communities because patients have so little options if they close their doors.

“Doctors I’ve spoken with spend 65 to 90% of their time checking boxes that CMS has put in front of them.” - Congresswoman Beth Van Duyne

Only a fraction of their days are being spent actually doing the job they signed up to do: treating their patients.

As Congressman Dan Meuser points out, phasing out the R&D tax credit is extremely harmful for businesses developing new medicine.

It’s extremely expensive to develop new medicines, and phasing this out only makes it that much harder for small companies.

WATCH: Pete Stauber explains that the patients and doctors should be in complete control of their care, not a bureaucrat at a three-letter agency.

Ensuring physicians are not undermined in giving care is essential to proper care.

As Blaine Luetkemeyer lays out, the FDA approval process is currently entirely too long and cumbersome.

Shortening that process, in a common sense way, will help providers and patients.